Michael P. Brugts

511 total citations
16 papers, 399 citations indexed

About

Michael P. Brugts is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Michael P. Brugts has authored 16 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Michael P. Brugts's work include Growth Hormone and Insulin-like Growth Factors (12 papers), Pituitary Gland Disorders and Treatments (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Michael P. Brugts is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (12 papers), Pituitary Gland Disorders and Treatments (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Michael P. Brugts collaborates with scholars based in Netherlands, Denmark and Germany. Michael P. Brugts's co-authors include J. A. M. J. L. Janssen, Leo J. Hofland, Steven W. J. Lamberts, Jan Frystyk, Annewieke W. van den Beld, Cornelia M. van Duijn, Aimee J. Varewijck, P. M. van Koetsveld, Michael B. Ranke and Karin Weber and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Michael P. Brugts

16 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael P. Brugts Netherlands 12 267 149 113 39 39 16 399
Laura C. Kutz United States 6 184 0.7× 102 0.7× 84 0.7× 44 1.1× 36 0.9× 9 367
Judith López‐Fernández Spain 10 169 0.6× 82 0.6× 71 0.6× 43 1.1× 21 0.5× 15 309
Megan Krumpoch United States 4 45 0.2× 261 1.8× 181 1.6× 79 2.0× 49 1.3× 7 385
Simona Garrone Italy 8 188 0.7× 83 0.6× 73 0.6× 27 0.7× 33 0.8× 8 353
Margot M. Linssen Netherlands 10 132 0.5× 133 0.9× 41 0.4× 27 0.7× 60 1.5× 18 382
S. Obradović Czechia 7 342 1.3× 66 0.4× 43 0.4× 44 1.1× 86 2.2× 9 455
Rhonda Souvenir United States 11 29 0.1× 238 1.6× 152 1.3× 54 1.4× 30 0.8× 14 438
Aline Villa Nova Bacurau Brazil 6 28 0.1× 137 0.9× 151 1.3× 22 0.6× 32 0.8× 7 336
Luis Jaime Castro‐Vega France 13 138 0.5× 252 1.7× 225 2.0× 24 0.6× 181 4.6× 20 663
Andreia Gonçalves Portugal 12 187 0.7× 136 0.9× 38 0.3× 37 0.9× 79 2.0× 16 497

Countries citing papers authored by Michael P. Brugts

Since Specialization
Citations

This map shows the geographic impact of Michael P. Brugts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Brugts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Brugts more than expected).

Fields of papers citing papers by Michael P. Brugts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Brugts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Brugts. The network helps show where Michael P. Brugts may publish in the future.

Co-authorship network of co-authors of Michael P. Brugts

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Brugts. A scholar is included among the top collaborators of Michael P. Brugts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Brugts. Michael P. Brugts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Janssen, J. A. M. J. L., Aimee J. Varewijck, & Michael P. Brugts. (2019). The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease. Growth Hormone & IGF Research. 48-49. 16–28. 10 indexed citations
2.
Spek, Ashley van der, Madeleine L. Drent, Michael P. Brugts, et al.. (2019). Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 11. 20–20. 24 indexed citations
3.
Herder, Wouter W. de, Kimberly Kamp, Michael P. Brugts, et al.. (2016). Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells. Neuroendocrinology. 103(6). 815–825. 12 indexed citations
4.
Bruijn, Renée F.A.G. de, J. A. M. J. L. Janssen, Michael P. Brugts, et al.. (2014). Insulin-Like Growth Factor-I Receptor Stimulating Activity is Associated with Dementia. Journal of Alzheimer s Disease. 42(1). 137–142. 22 indexed citations
5.
Kaščáková, Slávka, Leo J. Hofland, Henriëtte S. de Bruijn, et al.. (2014). Somatostatin Analogues for Receptor Targeted Photodynamic Therapy. PLoS ONE. 9(8). e104448–e104448. 16 indexed citations
6.
Beld, Annewieke W. van den, W. F. Blum, Michael P. Brugts, et al.. (2012). High IGFBP2 levels are not only associated with a better metabolic risk profile but also with increased mortality in elderly men. European Journal of Endocrinology. 167(1). 111–117. 23 indexed citations
7.
Varewijck, Aimee J., Michael P. Brugts, Jan Frystyk, et al.. (2012). Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling. Molecular and Cellular Endocrinology. 365(1). 17–24. 10 indexed citations
8.
Vitale, Giovanni, Michael P. Brugts, Giulia Ogliari, et al.. (2012). Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians’ offspring. Aging. 4(9). 580–589. 65 indexed citations
9.
Mesotten, Dieter, Michael P. Brugts, Willy Coopmans, et al.. (2011). Effect of Intensive Insulin Therapy on the Somatotropic Axis of Critically Ill Children. The Journal of Clinical Endocrinology & Metabolism. 96(8). 2558–2566. 15 indexed citations
10.
Brugts, Michael P.. (2010). IGF-I Bioactivity in Aging, Health and Disease. RePub (Erasmus University Rotterdam). 3 indexed citations
11.
Varewijck, Aimee J., Jeannette Goudzwaard, Michael P. Brugts, et al.. (2010). Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir. Growth Hormone & IGF Research. 20(6). 427–431. 17 indexed citations
12.
Brugts, Michael P., Cornelia M. van Duijn, Leo J. Hofland, et al.. (2010). IGF-I Bioactivity in an Elderly Population. Diabetes. 59(2). 505–508. 33 indexed citations
13.
Brugts, Michael P., T. Rietveld, J.L.D. Wattimena, et al.. (2009). Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients. Nephrology Dialysis Transplantation. 25(3). 940–946. 7 indexed citations
14.
Brugts, Michael P., et al.. (2009). Heterophilic antibodies may be a cause of falsely low total IGF1 levels. European Journal of Endocrinology. 161(4). 561–565. 17 indexed citations
15.
Brugts, Michael P., Annewieke W. van den Beld, Leo J. Hofland, et al.. (2008). Low Circulating Insulin-Like Growth Factor I Bioactivity in Elderly Men Is Associated with Increased Mortality. The Journal of Clinical Endocrinology & Metabolism. 93(7). 2515–2522. 72 indexed citations
16.
Brugts, Michael P., Michael B. Ranke, Leo J. Hofland, et al.. (2008). Normal Values of Circulating Insulin-Like Growth Factor-I Bioactivity in the Healthy Population: Comparison with Five Widely Used IGF-I Immunoassays. The Journal of Clinical Endocrinology & Metabolism. 93(7). 2539–2545. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura C. Kutz Breakdown of academic impact, for papers by Judith López‐Fernández Breakdown of academic impact, for papers by Megan Krumpoch Breakdown of academic impact, for papers by Simona Garrone Breakdown of academic impact, for papers by Margot M. Linssen Breakdown of academic impact, for papers by S. Obradović Breakdown of academic impact, for papers by Rhonda Souvenir Breakdown of academic impact, for papers by Aline Villa Nova Bacurau Breakdown of academic impact, for papers by Luis Jaime Castro‐Vega Breakdown of academic impact, for papers by Andreia Gonçalves
Rankless by CCL
2026